KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Jun 07, 2019 $4.87 $5.05 $4.80 $4.85 134 517
Jun 06, 2019 $4.97 $5.04 $4.77 $4.87 43 507
Jun 05, 2019 $4.99 $5.08 $4.67 $4.97 49 987
Jun 04, 2019 $4.77 $5.09 $4.74 $5.01 53 028
Jun 03, 2019 $4.88 $5.04 $4.67 $4.72 121 192
May 31, 2019 $4.91 $4.99 $4.70 $4.88 41 195
May 30, 2019 $4.51 $5.15 $4.51 $4.97 110 016
May 29, 2019 $4.91 $4.91 $4.44 $4.49 263 449
May 28, 2019 $4.96 $5.00 $4.85 $4.96 38 557
May 24, 2019 $5.06 $5.07 $4.91 $4.98 65 664
May 23, 2019 $5.17 $5.17 $4.99 $5.04 43 407
May 22, 2019 $5.24 $5.35 $5.15 $5.20 17 681
May 21, 2019 $5.33 $5.47 $5.29 $5.30 70 282
May 20, 2019 $5.28 $5.43 $5.14 $5.31 41 691
May 17, 2019 $5.28 $5.43 $5.21 $5.37 52 149
May 16, 2019 $5.49 $5.49 $4.80 $5.26 92 675
May 15, 2019 $5.27 $5.54 $5.26 $5.49 156 560
May 14, 2019 $4.98 $5.40 $4.85 $5.29 94 184
May 13, 2019 $5.18 $5.19 $4.75 $4.97 124 663
May 10, 2019 $4.88 $5.03 $4.77 $5.02 146 182
May 09, 2019 $5.00 $5.03 $4.79 $4.82 125 973
May 08, 2019 $5.27 $5.39 $4.96 $5.12 165 771
May 07, 2019 $5.49 $5.59 $5.34 $5.35 59 202
May 06, 2019 $5.35 $5.53 $5.33 $5.46 77 309
May 03, 2019 $5.36 $5.65 $5.36 $5.57 25 261
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT